CA200887 CellAura fluorescent M3 antagonist [pirenzepine]

Technical documents: SDS CoA Datasheet

Product overview

Name CA200887 CellAura fluorescent M3 antagonist [pirenzepine]
Biological description Fluorescent M3 muscarinic receptor antagonist (apparent KD values are 7.97, 6.29 and 6.24 for M3, M5 and M1 receptors respectively). Antagonizes the activity of carbachol, a muscarinic receptor agonist. Displays no intrinsic activity.
Alternative names CA200887|M3-633-AN
Purity >97%
Description Fluorescent M3 muscarinic receptor antagonist
Write Your Own Review
You're reviewing:CA200887 CellAura fluorescent M<sub>3</sub> antagonist [pirenzepine]
Rate this item:


Fluorescence imaging with HB7827

HB7827 (30 nM) binding to live CHO cells expressing muscarinic M3 receptors. Binding blocked by the unlabelled competitor 4-DAMP (10 µM). Nucli counter-stained with Hoechst.
Fluorescence imaging with HB7827
CellAura fluorescent M3 antagonist [pirenzepine] product vial image | Hello Bio

Biological Data

Application notes For imaging at the M3 receptor use solutions up to 100 nM.
Pharmacological validation The CellAura fluorescent M3 antagonist [pirenzepine] ligand was shown to antagonize the activity of the muscarinic agonist, carbachol, in a recombinant CHO cell line expressing the human M3 receptor and a serum-responsive secreted placental alkaline phosphatase (SPAP) reporter gene. The serum-induced expression of SPAP was measured under basal and serum-stimulated (maximal) conditions. Addition of CellAura fluorescent M3 antagonist [pirenzepine] to the basal or serum-stimulated cells did not significantly alter basal and stimulated SPAP levels, demonstrating that CellAura fluorescent M3 antagonist [pirenzepine] has no intrinsic agonist activity. To determine the apparent KD for CellAura fluorescent M3 antagonist [pirenzepine], cells were treated with varying concentrations of carbachol alone, or in the presence of 1µM CellAura fluorescent M3 antagonist [pirenzepine], and the serum-induced expression of SPAP measured. The apparent KD was calculated from the rightward shift of the agonist response curve in the presence of CellAura fluorescent M3 antagonist [pirenzepine], compared to the response curve for the agonist alone.

Solubility & Handling

Storage instructions -20°C (protect from light)
Solubility overview Soluble in DMSO
Handling After thawing individual aliquots for use, we recommend briefly sonicating the sample to ensure it is fully dissolved and the solution is homogeneous. We do not recommend using the product after subjecting it to repetitive freeze-thaw cycles.
Shipping conditions The product, supplied in a dry form, is stable at ambient temperature for periods of up to a few days and does not require shipping on ice/dry ice.
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.



More Info


More Info

Chemical Data

Purity >97%
Molecular Weight 1014
Source Synthetic
Formulation Lyophilized film
Excitation 633 nm
Emission 650 nm